July 27 (Reuters) - SynAct Pharma AB SYNACT.TE :
* SYNACT PHARMA ANNOUNCES OUTCOME IN THE EXERCISE OF
WARRANTS,
WILL RECEIVE APPROXIMATELY MSEK 32.4
* IS PROVIDED WITH A TOTAL OF APPROXIMATELY MSEK 32.4 BEFORE
ISSUE
COSTS
* WITH ISSUE PROCEEDS CO HAS SECURED CAPITAL NEEDED TO
FINANCE
SEVERAL IMPORTANT MILESTONES, SUCH AS DEMONSTRATING
PROOF-OF-CONCEPT FOR PHASE II STUDIES WITH AP1189 WITHIN RA AND
NS
Source text for Eikon: ID:nWkr1Q12n2
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))